Healthcare - Biotechnology - NASDAQ - US
$ 19.04
-5.74 %
$ 4.5 B
Market Cap
70.52
P/E
CASH FLOW STATEMENT
8.8 M
OPERATING CASH FLOW
-4.98 M
INVESTING CASH FLOW
-39 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
ADMA Biologics, Inc.
| Net Income | -28.2 M |
| Depreciation & Amortization | 8.33 M |
| Capital Expenditures | -4.98 M |
| Stock-Based Compensation | 6.19 M |
| Change in Working Capital | -10.1 M |
| Others | 40.2 M |
| Free Cash Flow | 3.82 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Jun-2011 | Jun-2010 | Jun-2009 | Jun-2008 | Jun-2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||
| Net Income | (28.2) | (65.9) | (71.6) | (75.7) | (48.3) | (65.7) | (43.8) | (19.5) | (18.0) | (16.8) | (15.5) | (7.3) | 26.5 K | 20.5 K | (20.0) | (24.9) | (29.7) |
| Depreciation & Amortization | 8.3 | 7.1 | 5.5 | 3.9 | 3.3 | 3.4 | 2.7 | 0.5 | 0.5 | 0.2 | 0.2 | 0.2 | 0 | 0.2 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0.2 | (0.9) | (1.4) | 0.1 | 1.9 | 0 | 0.7 | 74.4 K | 43.3 K | 18.4 K | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 6.2 | 5.2 | 3.5 | 2.9 | 2.7 | 0 | 1.6 | 1.3 | 1.7 | 1.2 | 0.9 | 0.6 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 32.6 | 12.4 | 1.8 | 1.6 | 1.0 | 1.0 | 0.6 | 0.5 | 0.4 | 0.4 | 0.1 | 7.47 K | 0 | (0.2) | (14.9) | 23.8 | 1.5 |
| Change in Working Capital | (10.1) | (18.3) | (51.7) | (33.8) | (33.5) | (3.7) | (0.3) | (1.0) | (0.7) | 0.2 | 3.4 | (0.4) | 2.54 K | 850 | 10.5 | (17.9) | 4.6 |
| Cash From Operations | 8.8 | (59.5) | (112.4) | (102.0) | (76.2) | (62.7) | (37.3) | (18.3) | (15.4) | (14.7) | (10.9) | (6.9) | 29 K | 19.7 K | (24.5) | (19.0) | (23.6) |
| INVESTING CASH FLOW | |||||||||||||||||
| Capital Expenditures | (5.0) | (13.9) | (13.5) | (12.7) | (3.8) | (2.1) | (2.7) | 73.4 K | 26.1 K | (2.3) | (0.2) | (0.1) | 0 | 0 | 0 | 0 | 0 |
| Other Items | 0 | 0 | 0 | 2 K | 0 | 0 | 17.9 | 1.0 | (1.7) | (1.7) | (2.9) | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (5.0) | (13.9) | (13.5) | (12.7) | (3.8) | (2.1) | 15.2 | 0.9 | (1.7) | (4.0) | (3.1) | (0.1) | 0 | 0 | 0 | 0 | 0 |
| FINANCING CASH FLOW | |||||||||||||||||
| Common Stock Repurchased | (1.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (23.6) | 51.7 | 34 K | 13.5 | 42.5 | 36.3 K | 25.0 | 4.0 | 0.7 | 9.8 | 1.0 | 3.7 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (3.9) | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (14.0) | (7.5) | 62 K | (0.8) | 37.5 | 13 K | (3.4) | 47.1 K | 9.7 | 42.1 K | (0.8) | (1.4) | 1.3 | 23 K | 30.5 | 7.0 | 12.5 K |
| Cash From Financing Activities | (39.0) | 108.9 | 121.0 | 143.9 | 80.0 | 42.9 | 60.8 | 16.8 | 10.4 | 9.8 | 27.6 | 19.5 | 25.5 K | 23 K | 30.5 | 7.0 | 12.5 |
| CHANGE IN CASH | |||||||||||||||||
| Net Change In Cash | (35.2) | 35.4 | (4.8) | 29.2 | 2.72 K | (21.9) | 38.7 | (0.5) | (6.8) | (9.0) | 13.6 | 12.4 | 3.5 K | 3.32 K | 6.0 | (12.0) | (11.1) |
| FREE CASH FLOW | |||||||||||||||||
| Free Cash Flow | 3.8 | (73.4) | (125.9) | (114.7) | (80.0) | (64.8) | (39.9) | (18.3) | (15.4) | (17.0) | (11.1) | (7.0) | 29 K | 19.7 K | (24.5) | (19.0) | (23.6) |